Skip to main content
Erschienen in: Archives of Dermatological Research 3/2023

23.09.2022 | COVID-19 | Short Report

Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center

verfasst von: Grace Y. Duan, Arlene M. Ruiz de Luzuriaga

Erschienen in: Archives of Dermatological Research | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Systemic isotretinoin is a highly effective treatment for severe and refractory acne but carries risk for serious adverse effects such as teratogenicity. The risk mitigation system used in the United States, iPLEDGE, requires all patients on isotretinoin therapy to complete monthly tasks including follow-up visits with their prescriber, and patients with childbearing potential must additionally undergo monthly pregnancy testing. Female patients seeking isotretinoin are disproportionately affected by iPLEDGE-related barriers and have historically been prescribed isotretinoin less than male patients. The onset of the COVID-19 pandemic and updated regulations permitting at-home pregnancy testing and telehealth for monthly follow-up visits presented an opportunity to study the impact of these changes on the isotretinoin gender gap. We performed a single-center analysis to determine whether gender differences in isotretinoin prescription changed at our institution at the beginning of the pandemic. We found that male predominance of isotretinoin prescriptions was greater during the pandemic compared to pre-pandemic (odds ratios: 4.13 vs. 2.86). Furthermore, male patients were more likely to utilize telehealth compared to in-person visits for isotretinoin follow-up relative to female patients (odds ratios: 6.00 vs. 3.62). Despite the newly introduced flexibilities of telehealth and remote pregnancy testing, gender inequity in receiving isotretinoin treatment persists.
Literatur
Metadaten
Titel
Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center
verfasst von
Grace Y. Duan
Arlene M. Ruiz de Luzuriaga
Publikationsdatum
23.09.2022
Verlag
Springer Berlin Heidelberg
Schlagwort
COVID-19
Erschienen in
Archives of Dermatological Research / Ausgabe 3/2023
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-022-02394-4

Weitere Artikel der Ausgabe 3/2023

Archives of Dermatological Research 3/2023 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.